Creatine phosphokinase levels in children with severe developmental disturbances

Area of Science:

• Child and Adolescent Psychiatry
• Neuroscience
• Biochemistry

Background:

• Childhood psychiatric disorders, including autism, schizophrenia, and personality disorders, represent a significant clinical challenge.
• Understanding biological markers may aid in early identification and intervention strategies.
• Creatine phosphokinase (CPK) is an enzyme found in muscle and brain tissue, and its serum levels can reflect cellular integrity.

Purpose of the Study:

• To investigate serum creatine phosphokinase (CPK) levels in children diagnosed with various psychiatric conditions.
• To compare CPK levels across different diagnostic groups and with healthy controls.
• To explore potential correlations between CPK levels and psychiatric vulnerability.

Main Methods:

• Serum CPK levels were measured in cohorts of children with childhood autism, atypical personality development, childhood schizophrenia, childhood aphasia, and severe personality disorders.
• Control groups included normal children, siblings of psychotic children, and parents of psychotic children.
• Statistical analysis was performed to compare CPK levels between groups and assess relationships with clinical factors.

Main Results:

• Mean serum CPK levels for most diagnostic groups were within normal limits.
• Children with severe personality disorders exhibited significantly higher CPK levels compared to other groups.
• No significant relationship was found between CPK levels and motor activity or psychoactive medication trials.

Conclusions:

• Elevated serum CPK levels in children with personality disorders may suggest a biological vulnerability.
• This finding could potentially relate to an increased risk for developing schizophrenic spectrum disorders later in life.
• Serum CPK levels demonstrated stability across test-retest assessments.